TGTX

NASDAQ HEALTHCARE

TG Therapeutics Inc

$53.89

-$1.50 (-2.71%)

Live quote

52w: $26.76 – $59.30

Loading chart…

P/E Ratio18.96

P/B Ratio14.04

EV/EBITDA—

Debt/Equity—

ROE74.03%

ROIC—

Revenue Growth87.32%

Gross Margin—

TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.

Own TGTX? Track it here.

Create a free account to add TGTX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account